Gastric activity on dipyridamole201T1 myocardial perfusion imaging

A clinically useful finding

V. V. Khary, Robert Nance, Jeffrey Stevens, R. A. Wilson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To determine the potential association of increased201T1 uptake by the stomach with symptoms referable to gastritis, 39 consecutive patients experiencing chest pain syndromes underwent a routine dipyridamole201T1 pharmacological stress test. With the patient in a fasting state, dipyridamole was infused intravenously (0.56 mg kg-1), shortly followed by201T1 infusion and subsequent image acquisition for single photon emission tomography (SPET). The original 32 SPET images over 180° of arc were interpreted without knowledge of clinical data, using a 4-point scoring system. Patients with active symptoms of gastro-oesophageal discomfort (n=17) were found to have significantly greater201T1 stomach uptake scores, compared to the little or no uptake in the 22 patients without such active symptoms (P=0.0001). A stepwise logistic regression analysis was used to determine which factor(s) showed independent predictive value of201T1 gastric uptake. The only two independent variables identified were the presence of active gastritis symptoms and the use of anti-gastritis medications. Elevated gastric201T1 uptake may be a clinically useful finding indicative of gastric inflammation that may be of value in the differential diagnosis of chest and epigastric discomfort.

Original languageEnglish (US)
Pages (from-to)477-482
Number of pages6
JournalNuclear Medicine Communications
Volume16
Issue number6
StatePublished - 1995

Fingerprint

Myocardial Perfusion Imaging
Stomach
Gastritis
Photons
Tomography
Dipyridamole
Chest Pain
Exercise Test
Fasting
Differential Diagnosis
Thorax
Logistic Models
Regression Analysis
Pharmacology
Inflammation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Gastric activity on dipyridamole201T1 myocardial perfusion imaging : A clinically useful finding. / Khary, V. V.; Nance, Robert; Stevens, Jeffrey; Wilson, R. A.

In: Nuclear Medicine Communications, Vol. 16, No. 6, 1995, p. 477-482.

Research output: Contribution to journalArticle

@article{8eda5c7a39f4404aa34299f50bea475a,
title = "Gastric activity on dipyridamole201T1 myocardial perfusion imaging: A clinically useful finding",
abstract = "To determine the potential association of increased201T1 uptake by the stomach with symptoms referable to gastritis, 39 consecutive patients experiencing chest pain syndromes underwent a routine dipyridamole201T1 pharmacological stress test. With the patient in a fasting state, dipyridamole was infused intravenously (0.56 mg kg-1), shortly followed by201T1 infusion and subsequent image acquisition for single photon emission tomography (SPET). The original 32 SPET images over 180° of arc were interpreted without knowledge of clinical data, using a 4-point scoring system. Patients with active symptoms of gastro-oesophageal discomfort (n=17) were found to have significantly greater201T1 stomach uptake scores, compared to the little or no uptake in the 22 patients without such active symptoms (P=0.0001). A stepwise logistic regression analysis was used to determine which factor(s) showed independent predictive value of201T1 gastric uptake. The only two independent variables identified were the presence of active gastritis symptoms and the use of anti-gastritis medications. Elevated gastric201T1 uptake may be a clinically useful finding indicative of gastric inflammation that may be of value in the differential diagnosis of chest and epigastric discomfort.",
author = "Khary, {V. V.} and Robert Nance and Jeffrey Stevens and Wilson, {R. A.}",
year = "1995",
language = "English (US)",
volume = "16",
pages = "477--482",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Gastric activity on dipyridamole201T1 myocardial perfusion imaging

T2 - A clinically useful finding

AU - Khary, V. V.

AU - Nance, Robert

AU - Stevens, Jeffrey

AU - Wilson, R. A.

PY - 1995

Y1 - 1995

N2 - To determine the potential association of increased201T1 uptake by the stomach with symptoms referable to gastritis, 39 consecutive patients experiencing chest pain syndromes underwent a routine dipyridamole201T1 pharmacological stress test. With the patient in a fasting state, dipyridamole was infused intravenously (0.56 mg kg-1), shortly followed by201T1 infusion and subsequent image acquisition for single photon emission tomography (SPET). The original 32 SPET images over 180° of arc were interpreted without knowledge of clinical data, using a 4-point scoring system. Patients with active symptoms of gastro-oesophageal discomfort (n=17) were found to have significantly greater201T1 stomach uptake scores, compared to the little or no uptake in the 22 patients without such active symptoms (P=0.0001). A stepwise logistic regression analysis was used to determine which factor(s) showed independent predictive value of201T1 gastric uptake. The only two independent variables identified were the presence of active gastritis symptoms and the use of anti-gastritis medications. Elevated gastric201T1 uptake may be a clinically useful finding indicative of gastric inflammation that may be of value in the differential diagnosis of chest and epigastric discomfort.

AB - To determine the potential association of increased201T1 uptake by the stomach with symptoms referable to gastritis, 39 consecutive patients experiencing chest pain syndromes underwent a routine dipyridamole201T1 pharmacological stress test. With the patient in a fasting state, dipyridamole was infused intravenously (0.56 mg kg-1), shortly followed by201T1 infusion and subsequent image acquisition for single photon emission tomography (SPET). The original 32 SPET images over 180° of arc were interpreted without knowledge of clinical data, using a 4-point scoring system. Patients with active symptoms of gastro-oesophageal discomfort (n=17) were found to have significantly greater201T1 stomach uptake scores, compared to the little or no uptake in the 22 patients without such active symptoms (P=0.0001). A stepwise logistic regression analysis was used to determine which factor(s) showed independent predictive value of201T1 gastric uptake. The only two independent variables identified were the presence of active gastritis symptoms and the use of anti-gastritis medications. Elevated gastric201T1 uptake may be a clinically useful finding indicative of gastric inflammation that may be of value in the differential diagnosis of chest and epigastric discomfort.

UR - http://www.scopus.com/inward/record.url?scp=0029054605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029054605&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 477

EP - 482

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 6

ER -